{"DataElement":{"publicId":"2660011","version":"2","preferredName":"Breast Carcinoma Mutation Probability Model","preferredDefinition":"Text term for a model that evaluates the mutation probability of breast cancer.","longName":"BRST_CA_PROB_MDL_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2659939","version":"1","preferredName":"Breast Carcinoma Mutation Probability Model","preferredDefinition":"Use of a conceptual model to evaluate the mutation probability of developing breast cancer. [Manually-curated]","longName":"BRST_CA_MUT_PROB_MDL","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2659936","version":"1","preferredName":"Breast Carcinoma Mutation","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","longName":"C4872:C16885","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation","conceptCode":"C16885","definition":"Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BF671D-2B5D-5C57-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2659947","version":"1","preferredName":"Probability Model","preferredDefinition":"A measure of the expectation of the occurrence of a particular event.:1. A representation of something, often idealized or modified to make it conceptually easier to understand. 2. Something to be imitated. 3. In dentistry, a cast.","longName":"C54154:C16866","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Probability","conceptCode":"C54154","definition":"A measure of the expectation of the occurrence of a particular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Model","conceptCode":"C16866","definition":"A representation of something, often idealized or modified to make it conceptually easier to understand.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BE8222-5BBC-6322-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BF671D-2B7F-5C57-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2659944","version":"2","preferredName":"Breast Carcinoma Probability Model Name","preferredDefinition":"Names of conceptual models used to evaluate the mutation probability of developing breast cancer.","longName":"BRST_CA_PROB_MDL_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Claus","valueDescription":"Claus Model","ValueMeaning":{"publicId":"2659946","version":"1","preferredName":"Claus Model","longName":"2659946","preferredDefinition":"Claus model for calculating probability of developing breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BE822E-6258-6827-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A28BBD69-3E4B-307E-E040-BB89AD4331A4","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"},{"value":"BRCAPRO","valueDescription":"BRCAPRO Model","ValueMeaning":{"publicId":"2659945","version":"1","preferredName":"BRCAPRO Model","longName":"2659945","preferredDefinition":"BRCAPRO model for calculating mutation probability of breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BE822E-6232-6827-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A28BBD69-3E55-307E-E040-BB89AD4331A4","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"},{"value":"Tyrer-Cuzick","valueDescription":"A model designed to predict 10-year risk of breast cancer development, in a well-defined cohort of women with atypia.  The Tyrer-Cuzick model incorporates both genetic and nongenetic factors.","ValueMeaning":{"publicId":"3130993","version":"1","preferredName":"A model designed to predict 10-year risk of breast cancer development, in a well-defined cohort of women with atypia.  The Tyrer-Cuzick model incorporates both genetic and nongenetic factors.","longName":"3130993","preferredDefinition":"A model designed to predict 10-year risk of breast cancer development, in a well-defined cohort of women with atypia.  The Tyrer-Cuzick model incorporates both genetic and nongenetic factors.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E310A94-42C6-DD37-E040-BB89AD4337F5","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A28BBD69-3E5F-307E-E040-BB89AD4331A4","beginDate":"2010-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"},{"value":"BOADICEA","valueDescription":"(Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm, Antoniou et al., 2004, 2008) is a risk model for familial breast and ovarian cancer.","ValueMeaning":{"publicId":"3130994","version":"1","preferredName":"(Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm, Antoniou et al., 2004, 2008) is a risk model for familial breast and ovarian cancer.","longName":"3130994","preferredDefinition":"(Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm, Antoniou et al., 2004, 2008) is a risk model for familial breast and ovarian cancer.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E310A94-42E9-DD37-E040-BB89AD4337F5","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A28BBD69-3E69-307E-E040-BB89AD4331A4","beginDate":"2010-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"},{"value":"Shattuck-Eidens","valueDescription":"Shattuck-Eidens","ValueMeaning":{"publicId":"3234063","version":"1","preferredName":"Shattuck-Eidens","longName":"3234063","preferredDefinition":"Shattuck-Eidens","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A28BBD69-3E7A-307E-E040-BB89AD4331A4","latestVersionIndicator":"Yes","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A28BBD69-3E93-307E-E040-BB89AD4331A4","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"},{"value":"Couch","valueDescription":"Couch Model","ValueMeaning":{"publicId":"3234064","version":"1","preferredName":"Couch Model","longName":"3234064","preferredDefinition":"Couch Model","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A28BBD69-3E9D-307E-E040-BB89AD4331A4","latestVersionIndicator":"Yes","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A28BBD69-3EB6-307E-E040-BB89AD4331A4","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"},{"value":"Manchester Scoring System","valueDescription":"Manchester Scoring System","ValueMeaning":{"publicId":"3234065","version":"1","preferredName":"Manchester Scoring System","longName":"3234065","preferredDefinition":"Manchester Scoring System","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A28BBD69-3EC0-307E-E040-BB89AD4331A4","latestVersionIndicator":"Yes","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A28BBD69-3ED9-307E-E040-BB89AD4331A4","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"},{"value":"Myriad for Professionals Risk Calculator (Frank)","valueDescription":"Myriad for Professionals Risk Calculator (Frank Model)","ValueMeaning":{"publicId":"3234066","version":"1","preferredName":"Myriad for Professionals Risk Calculator (Frank Model)","longName":"3234066","preferredDefinition":"Myriad for Professionals Risk Calculator (Frank Model)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A28BBD69-3EE3-307E-E040-BB89AD4331A4","latestVersionIndicator":"Yes","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A28BBD69-3EFC-307E-E040-BB89AD4331A4","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"ONEDATA","dateModified":"2011-05-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2659943","version":"1","preferredName":"Breast Carcinoma Probability Model Name","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:A measure of the expectation of the occurrence of a particular event.:1. A representation of something, often idealized or modified to make it conceptually easier to understand. 2. Something to be imitated. 3. In dentistry, a cast.:The words or language units by which a thing is known.","longName":"C4872:C54154:C16866:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Probability","conceptCode":"C54154","definition":"A measure of the expectation of the occurrence of a particular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Model","conceptCode":"C16866","definition":"A representation of something, often idealized or modified to make it conceptually easier to understand.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BE8222-5B93-6322-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A28BBD69-3E35-307E-E040-BB89AD4331A4","latestVersionIndicator":"Yes","beginDate":"2011-05-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"REEVESD","dateModified":"2011-05-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812183","version":"1","longName":"Atrovastatin in Women at High Risk for Breast Cancer","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Model/Data used","type":"Preferred Question Text","description":"Model/Data used","url":null,"context":"CCR"},{"name":"Model Used","type":"Alternate Question Text","description":"Model Used","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A28C426D-5846-E1D9-E040-BB89AD435D39","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-05","modifiedBy":"MAESKEB","dateModified":"2012-07-16","changeDescription":"Repalces v1.0 with extended maximum field length from 20 to 50 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}